These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37902170)

  • 1. Transplacental non-steroidal anti-inflammatory drugs versus expectant management in fetal Ebstein anomaly with circular shunt: Systematic review and meta-analysis.
    Mustafa HJ; Aghajani F; Bairmani ZA; Khalil A
    Prenat Diagn; 2024 Jun; 44(6-7):773-782. PubMed ID: 37902170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).
    Freud LR; Wilkins-Haug LE; Beroukhim RS; LaFranchi T; Phoon CK; Glickstein JS; Cumbermack KM; Makhoul M; Morris SA; Sun HY; Ferrer Q; Pedra SR; Tworetzky W
    Am J Cardiol; 2021 Feb; 141():106-112. PubMed ID: 33217351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study.
    Freud LR; Escobar-Diaz MC; Kalish BT; Komarlu R; Puchalski MD; Jaeggi ET; Szwast AL; Freire G; Levasseur SM; Kavanaugh-McHugh A; Michelfelder EC; Moon-Grady AJ; Donofrio MT; Howley LW; Tierney ES; Cuneo BF; Morris SA; Pruetz JD; van der Velde ME; Kovalchin JP; Ikemba CM; Vernon MM; Samai C; Satou GM; Gotteiner NL; Phoon CK; Silverman NH; McElhinney DB; Tworetzky W
    Circulation; 2015 Aug; 132(6):481-9. PubMed ID: 26059011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Severe Fetal Ebstein's Anomaly with Prenatal Nonsteroidal Anti-Inflammatory Therapy.
    Powel JE; Kraus E; Reddy C; Lannaman K
    Fetal Diagn Ther; 2022; 49(5-6):245-249. PubMed ID: 35728558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal circular shunt in Ebstein's anomaly and non-steroidal anti-inflammatory treatment.
    Peña FL; Emanuelson TW; Todman SH; Jones RC; Mahajan S
    J Neonatal Perinatal Med; 2024; 17(1):63-69. PubMed ID: 38217614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal echocardiographic prediction score for perinatal mortality in tricuspid valve dysplasia and Ebstein's anomaly.
    Torigoe F; Ishida H; Ishii Y; Ishii R; Narita J; Kawazu Y; Kayatani F; Inamura N
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):226-232. PubMed ID: 31008542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fetal circular shunt with non-steroidal anti-inflammatory drugs.
    Torigoe T; Mawad W; Seed M; Ryan G; Marini D; Golding F; VAN Mieghem T; Jaeggi E
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):841-846. PubMed ID: 30381862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The American Association for Thoracic Surgery (AATS) 2024 expert consensus document: Management of neonates and infants with Ebstein anomaly.
    Konstantinov IE; Chai P; Bacha E; Caldarone CA; Da Silva JP; Da Fonseca Da Silva L; Dearani J; Hornberger L; Knott-Craig C; Del Nido P; Qureshi M; Sarris G; Starnes V; Tsang V
    J Thorac Cardiovasc Surg; 2024 Aug; 168(2):311-324. PubMed ID: 38685467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Outcomes and Factors Associated With Mortality After a Fetal or Neonatal Diagnosis of Ebstein Anomaly and Tricuspid Valve Disease.
    Wertaschnigg D; Manlhiot C; Jaeggi M; Seed M; Dragulescu A; Schwartz SM; van Arsdell G; Jaeggi ET
    Can J Cardiol; 2016 Dec; 32(12):1500-1506. PubMed ID: 27476984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Assessment of Left Ventricular Dysfunction in Fetal Ebstein's Anomaly and Tricuspid Valve Dysplasia.
    Eckersley LG; Howley LW; van der Velde ME; Khoo NS; Mah K; Brooks P; Colen T; Hornberger LK
    J Am Soc Echocardiogr; 2019 Dec; 32(12):1598-1607. PubMed ID: 31551185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Progressive Pathophysiology After Early Prenatal Diagnosis of the Ebstein Anomaly or Tricuspid Valve Dysplasia.
    Selamet Tierney ES; McElhinney DB; Freud LR; Tworetzky W; Cuneo BF; Escobar-Diaz MC; Ikemba C; Kalish BT; Komarlu R; Levasseur SM; Puchalski MD; Satou GM; Silverman NH; Moon-Grady AJ
    Am J Cardiol; 2017 Jan; 119(1):106-111. PubMed ID: 27793395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent irreversible closure of arterial duct following therapeutic use of transplacental indomethacin in a fetus with severe Ebstein's anomaly and circular shunt.
    Gill K; Arbic N; Seed M; Honjo O; Ryan G; Jaeggi E
    Ultrasound Obstet Gynecol; 2021 Dec; 58(6):940-942. PubMed ID: 34453368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fetal haemodynamics on surgical and neurodevelopmental outcomes in patients with Ebstein anomaly and tricuspid valve dysplasia.
    Bao M; Jaeggi E; Sun L; Lee FT; Sananes R; Chau V; Macgowan CK; Miller SP; Seed M; Marini D
    Cardiol Young; 2022 Nov; 32(11):1768-1779. PubMed ID: 34986918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal outcomes following early prenatal diagnosis: insights from a single-center experience with Ebstein anomaly and tricuspid valve dysplasia.
    Dedeoglu R; Akbulut DG; Turkmen E; Dedeoglu S; Bornaun H
    Arch Gynecol Obstet; 2024 Sep; 310(3):1491-1497. PubMed ID: 38683395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.
    Freud LR; McElhinney DB; Kalish BT; Escobar-Diaz MC; Komarlu R; Puchalski MD; Jaeggi ET; Szwast AL; Freire G; Levasseur SM; Kavanaugh-McHugh A; Michelfelder EC; Moon-Grady AJ; Donofrio MT; Howley LW; Selamet Tierney ES; Cuneo BF; Morris SA; Pruetz JD; van der Velde ME; Kovalchin JP; Ikemba CM; Vernon MM; Samai C; Satou GM; Gotteiner NL; Phoon CK; Silverman NH; Tworetzky W
    J Am Heart Assoc; 2020 Nov; 9(21):e016684. PubMed ID: 33076749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Ebstein's anomaly with circular shunt: from successful fetal therapy with non-steroidal anti-inflammatory drugs to biventricular repair using Da Silva cone technique.
    Lopes LM; Bezerra RF; da Silva JP; da Fonseca da Silva L
    Cardiol Young; 2021 Jun; 31(6):1039-1042. PubMed ID: 33682656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circular shunting of blood: a complication of neonatal Ebstein anomaly].
    Paranon S; Plat-Wilson G; Marcoux MO; Acar P
    Arch Pediatr; 2010 Dec; 17(12):1673-6. PubMed ID: 21074386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-gestation prediction of outcome in tricuspid valve dysplasia and Ebstein's anomaly using fetal tricuspid regurgitation waveform analysis.
    Ikegawa T; Kim KS; Kawataki M; Ichikawa Y; Ono S; Yanagi S; Ueda H
    Ultrasound Obstet Gynecol; 2023 May; 61(5):593-600. PubMed ID: 36273401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
    Mitra S; Scrivens A; von Kursell AM; Disher T
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal course of Ebstein's anomaly and tricuspid valve dysplasia in the fetus.
    Lasa JJ; Tian ZY; Guo R; Rychik J
    Prenat Diagn; 2012 Mar; 32(3):245-51. PubMed ID: 22430722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.